Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Nov 18;12(11):3430.
doi: 10.3390/cancers12113430.

Is Laparoscopic Pancreaticoduodenectomy Feasible for Pancreatic Ductal Adenocarcinoma?

Affiliations
Review

Is Laparoscopic Pancreaticoduodenectomy Feasible for Pancreatic Ductal Adenocarcinoma?

Chang Moo Kang et al. Cancers (Basel). .

Abstract

Margin-negative radical pancreatectomy is the essential condition to obtain long-term survival of patients with pancreatic cancer. With the investigation for early diagnosis, introduction of potent chemotherapeutic agents, application of neoadjuvnat chemotherapy, advancement of open and laparoscopic surgical techniques, mature perioperative management, and patients' improved general conditions, survival of the resected pancreatic cancer is expected to be further improved. According to the literatures, laparoscopic pancreaticoduodenectomy (LPD) is also thought to be good alternative strategy in managing well-selected resectable pancreatic cancer. LPD with combined vascular resection is also feasible, but only expert surgeons should handle these challenging cases. LPD for pancreatic cancer should be determined based on surgeons' proficiency to fulfil the goals of the patient's safety and oncologic principles.

Keywords: laparoscopic; pancreatic cancer; pancreaticoduodenectomy.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Laparoscopic view after resection of pancreatic head cancer. BD; bile duct, PV; portal vein, CHA; common hepatic artery. P; pancreas, SV; splenic vein, SMV; superior mesenteric vein, SMA; superior mesenteric artery, LRV; left renal vein, IVC; inferior vena cava, gastroduodenal artery stump (white arrows), pancreatic duct (thick white arrow).
Figure 2
Figure 2
Intraoperative usage of indocyanine green (ICG) during obtaining the retroperitoneal margin of the pancreas. The ICG stained area is part of the uncinated process (a), which can be differentiated from the SMA to obtain the retroperitoneal margin (b). It can help the surgeon design surgical dissection. Note soft tissue around the SMA (retroperitoneal margin) is not stained by ICG. P; uncinated process of the pancreas, SMA; superior mesenteric artery, SMV; superior mesenteric vein, RPM; retroperitoneal margin.
Figure 3
Figure 3
Combined venous vascular resection during laparoscopic pancreaticoduodenectomy (LPD). Tangential wedge resection of SMV is performed after transient clamping venous system (a). Primary repair of resected venous system (b). Tangential resection line (white dotted line), tumor invasion (white *), primary repair (white arrows).
Figure 4
Figure 4
Model for determining surgical indication of LPD for pancreatic cancer. Regardless of laparoscopic or open PD for pancreatic cancer, surgical approach should be allowed only when surgeons’ technical feasibility can obtain the appropriate surgical extent for margin-negative resection. Therefore, indication of LPD can vary according to surgeons’ techniques and disease extent. OPD will be recommended in surgeon (A). Type 0 LPD can be done in surgeon (B). Type Ia LPD and Type Ib LPD can be allowed for surgeon (C) and surgeon (D), respectively. Anatomically resectable pancreatic cancer with intact fat plane between pancreas and major vascular structures is thought to be the ideal tumor conditions for LPD (Tumor conditions controlled by Type 0 LPD). Note: This author follows Fortner’s initial classification of regional pancreatectomy [96].
Figure 5
Figure 5
A case with extremely appropriate pancreatic cancer for LPD. A case of early pancreatic cancer in a 71-year-old, male patient, incidental finding of pancreatic duct dilatation during routine medical check-up. Preoperative image studies showed less than 1 cm sized pancreatic mass with secondary pancreatic duct dilatation (a,b). Type 0 LPD was performed on 24 October 2019, and discharged 9 days postoperatively. Pathological examination reported 3.0 mm-sized pancreatic ductal adenocarcinoma with good differentiation (×100, c). resected margins were free from malignant cells (safety margin ≥ 1 cm). No lymph node metastasis was noted among 23 retrieved lymph nodes.

References

    1. Stocken D.D., Büchler M.W., Dervenis C., Bassi C., Jeekel H., Klinkenbijl J.H., Bakkevold K.E., Takada T., Amano H., Neoptolemos J.P. Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer. Br. J. Cancer. 2005;92:1372–1381. doi: 10.1038/sj.bjc.6602513. - DOI - PMC - PubMed
    1. Parmar A., Chaves-Porras J., Saluja R., Perry K., Rahmadian A.P., Santos S.D., Ko Y.J., Berry S., Doherty M., Chan K.K.W. Adjuvant treatment for resected pancreatic adenocarcinoma: A systematic review and network meta-analysis. Crit. Rev. Oncol. Hematol. 2020;145:102817. doi: 10.1016/j.critrevonc.2019.102817. - DOI - PubMed
    1. Rahib L., Smith B.D., Aizenberg R., Rosenzweig A.B., Fleshman J.M., Matrisian L.M. Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States. Cancer Res. 2014;74:2913. doi: 10.1158/0008-5472.CAN-14-0155. - DOI - PubMed
    1. Kang C.M., Lee S.H., Chung M.J., Hwang H.K., Lee W.J. Laparoscopic pancreatic reconstruction technique following laparoscopic pancreaticoduodenectomy. J. Hepatobiliary Pancreat. Sci. 2015;22:202–210. doi: 10.1002/jhbp.193. - DOI - PubMed
    1. De Rooij T., van Hilst J., van Santvoort H., Boerma D., van den Boezem P., Daams F., van Dam R., Dejong C., van Duyn E., Dijkgraaf M., et al. Minimally Invasive Versus Open Distal Pancreatectomy (LEOPARD): A Multicenter Patient-blinded Randomized Controlled Trial. Ann. Surg. 2019;269:2–9. doi: 10.1097/SLA.0000000000002979. - DOI - PubMed

LinkOut - more resources